The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Disorders of Bone Remodeling
Open accessAbstract
The skeleton provides mechanical support for stature and locomotion, protects vital organs, and controls mineral homeostasis. A healthy skeleton must be maintained by constant bone modeling to carry out these crucial functions throughout life. Bone remodeling involves the removal of old or damaged bone by osteoclasts (bone resorption) and the subsequent replacement of new bone formed by osteoblasts (bone formation). Normal bone remodeling requires a tight coupling of bone resorption to bone formation to guarantee no alteration in bone mass or quality after each remodeling cycle. However, this important physiological process can be derailed by a variety of factors, including menopause-associated hormonal changes, age-related factors, changes in physical activity, drugs, and secondary diseases, which lead to the development of various bone disorders in both women and men. We review the major diseases of bone remodeling, emphasizing our current understanding of the underlying pathophysiological mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“OPG, a soluble receptor also produced by osteoblasts that acts as a decoy receptor and neutralizes RANKL, prevents RANKL from interacting with RANK and consequently inhibits osteoclast proliferation, activity, and survival [73, 74].”
From The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms (2018) · cites this paper as [73]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Once RANKL binds to its natural receptor, expressed by osteoclast precursor cells, it stimulates osteoclast precursor differentiation to active mature osteoclasts and accelerates bone resorption [73].”
From The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms (2018) · cites this paper as [73]
In the citing paper
“Abnormal increase in osteoclast formation and activity leads to some bone diseases such as osteoporosis, where resorption exceeds formation causing decreased bone density and increased bone fractures [105].”
From Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells (2015) · cites this paper as [105]
In the citing paper
“In patients with chronic liver disease, the balance between osteoclasts and osteoblasts is affected by liver disease, resulting in BRU imbalance [46,50].”
From Bone diseases in patients with chronic liver disease (2019) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidants, oxidative stress and the biology of ageing
Finkel, T., & Holbrook, N. J. (2000) · Nature · doi:10.1038/35041687 · Cited by 9,413
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670
Osteoporosis Prevention, Diagnosis, and Therapy
NIH Consensus Development Panel on Osteoporosis Prevention, D. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.6.785 · Cited by 5,529
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Mitochondria, Oxidants, and Aging
Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,639
Research works printed but not linked: 11
- McGowen JA, 2004, Bone Health and Osteoporosis: A Report of the Surgeon General, 69
- Raisz LG., 1988, Ciba Found. Symp., 136, 226
- Mundy GR., 1991, Ciba Found. Symp., 157, 137
- Andersen TL, 2009, Br. J. Haematol., 48, 551
- Heaney RP, 1978, J. Lab. Clin. Med., 92, 964
- 10.1210/en.142.6.2205 · DOI · Paper page
- 10.1172/JCI200317215 · DOI · Paper page
- 10.1210/jc.83.12.4257 · DOI
- Peretz A, 1989, J. Rheumatol., 16, 363
- Takata S, 2001, J. Med. Investig., 48, 147
- Block GA, 2006, Clinical Guide to the Basics of Bone and Mineral Metabolism in CKD, 77
Cited by
Sorted by citations
Items 701–800 of 1,000
Xu, K., Chen, Z., Hou, J., Dong, C., Shi, C., Gao, L., Huang, Z., Shen, G., Wang, T., & Zhou, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113529 · Cited by 10
Ma, F., Zhang, W., Zhou, G., Qi, Y., Mao, H.-R., Chen, J., Lu, Z., Wu, W., Zou, X., Deng, D., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112472 · Cited by 10
Optimizing dental implant design: Structure, strength, and bone ingrowth
Chang, J. Z., Hsu, J., Li, M., Lin, H., Sun, J., Tsou, N., & Sun, J.-S. (2024) · Journal of Dental Sciences · doi:10.1016/j.jds.2024.11.024 · Cited by 10
3D-Bioprinted Oil-Based Hydrogels: A Sustainable Approach for Bone and Dental Regeneration
Masri, S., Mohd, N., Kasim, N. H. A., & Razali, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083510 · Cited by 10
Nrf2 signaling in bone health: unlocking new avenues for osteoporosis management
Lavhale, M. P., Mandlik, S. K., Shinde, V. M., & Mandlik, D. S. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01985-7 · Cited by 10
“Its composition includes approximately 60% mineral crys-tals—primarily hydroxyapatite—alongside 10% cells and 30% organic matrix (Feng And McDonald 2011).”
Biomimetic mineralization of collagen: mechanisms, applications, and prospects
Pan, Z., Wang, Y., Cui, C., Sun, Z., Ying, J., Wu, J., & Su, W. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148294 · Cited by 11
Langlois, J., Zaoui, A., Bichara, D. A., Nich, C., Bensidhoum, M., Petite, H., Muratoglu, O. K., & Hamadouche, M. (2015) · Journal of Orthopaedic Research® · doi:10.1002/jor.23050 · Cited by 10
“Beyond that, various chronic bone disorders can be explained by a shifting of this couple.(43) According to these principles, periprosthetic particleinduced disease should most likely integrate a downregulated bone repair component.”
BackgroundC/EBPα and PU.1 exhibit different responses to RANK signaling for osteoclastogenesis
Jules, J., Li, Y., & Chen, W. (2017) · Bone · doi:10.1016/j.bone.2017.05.009 · Cited by 11
“However, in many bone diseases, the rate of bone resorption exceeds that of bone formation [3,4].”
BackgroundEckert, D., Rapp, F., Tsedeke, A. T., Kraft, D., Wente, I., Molendowska, J., Basheer, S., Langhans, M., Meckel, T., Friedrich, T., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.817281 · Cited by 10
“In healthy bone tissue, a highly regulated homeostasis is maintained (11).”
BackgroundLefferts, W. K., Davis, M. M., & Valentine, R. J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.866792 · Cited by 13
“Though exercise has long been known to stimulate bone mineralization and promote increased bone density, the initial response following any mechanical stimulus such as exercise is the resorption/breakdown of bone (Feng and McDonald, 2011).”
BackgroundMechanistic insight of interleukin‐9 induced osteoclastogenesis
Chakraborty, S., Schneider, J., Mitra, D. K., & Kubatzky, K. F. (2023) · Immunology · doi:10.1111/imm.13630 · Cited by 11
“An imbalance in this process is often observed in various skeletal disorders [1].”
BackgroundTian, J., Yang, F., Bao, X., Jiang, Q., Li, Y., Kang, Y., & Yin, Y. (2023) · Animals · doi:10.3390/ani13040569 · Cited by 10
“The maintenance of bone homeostasis is dependent upon the equilibrium between osteoblast-mediated bone matrix formation and bone osteoclast-mediated resorption in adults, whereas in adolescence, bone homeostasis tends to be dominated by osteoblastmediated bone matrix formation to support bone growth and development [1…”
BackgroundPark, P. S. U., Resto, D. A., Khurana, N., Raynor, W., Werner, T. J., Høilund‐Carlsen, P. F., & Alavi, A. A. (2023) · Spine · doi:10.1097/brs.0000000000004640 · Cited by 10
Bouzid, A., Tekari, A., Jbeli, F., Chakroun, A., Hansdah, K., Souissi, A., Singh, N., Mosrati, M. A., Achour, I., Ghorbel, A., et al. (2020) · BMC Medical Genetics · doi:10.1186/s12881-020-01036-8 · Cited by 10
Sattgast, L. H., Branscum, A. J., Walter, N. A. R., Newman, N., Gonzales, S. W., Grant, K. A., Turner, R. T., & Iwaniec, U. T. (2021) · Alcohol · doi:10.1016/j.alcohol.2020.12.003 · Cited by 10
Diabetoporosis: Role of nitric oxide
Yousefzadeh, N., Jeddi, S., Kashfi, K., & Ghasemi, A. (2021) · EXCLI journal · doi:10.17179/excli2021-3541 · Cited by 14
“Bone remodeling has four consecutive steps including activation, resorption, reversal, and formation, which require a coordinated action of the bone cells, including osteocytes, osteoblasts, osteoclasts, and bone-lining cells (Feng and McDonald, 2011).”
BackgroundBae, J.-H., & Park, D.-J. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.01.020 · Cited by 10
Kim, K., Yoon, Y., Bo, L.-Y., & Suh, J. (2022) · Journal of Bone Metabolism · doi:10.11005/jbm.2022.29.2.123 · Cited by 9
“[24] Diverse risk factors, including aging and estrogen deprivation, cause bone cell apoptosis and loss of mineral matrix in bone tissue, leading to osteopenia and osteoporosis.[25,26] Atherosclerosis is also a conTable 3.”
BackgroundMifsud, S., Mifsud, E. L., Agius, S. M., Mula, A., & Gruppetta, M. (2022) · British Journal of Hospital Medicine · doi:10.12968/hmed.2021.0624 · Cited by 10
The Ying and Yang of Sphingosine-1-Phosphate Signalling within the Bone
Frost, K., Naylor, A. J., & McGettrick, H. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086935 · Cited by 12
“Disruption of this delicate balance can occur with age and in a variety of inflammatory disorders and cancer, leading to abnormal bone mineral density and increased risk of fracture [2].”
BackgroundShang, P., ZHANG, J., Qian, A., Li, J., Meng, R., Di, S., Hu, L., & Gu, Z. (2013) · Journal of Mechanics in Medicine and Biology · doi:10.1142/s021951941340006x · Cited by 10
PP2A regulatory subunit B55γ is a gatekeeper of osteoblast maturation and lineage maintenance
Serguienko, A., Hanes, R., Grad, I., Wang, M. Y., Myklebost, O., & Munthe, E. (2017) · Stem Cells and Development · doi:10.1089/scd.2017.0129 · Cited by 9
Effect of Spinach Extract on RANKL-Mediated Osteoclast Differentiation
Kim, D.-G., Kim, M.-H., Kang, M., & Shin, J. H. (2015) · Journal of the Korean Society of Food Science and Nutrition · doi:10.3746/jkfn.2015.44.4.532 · Cited by 9
Singh, T., Singh, T. S. J., & Chin, K. (2024) · Pharmaceuticals · doi:10.3390/ph17020146 · Cited by 9
“The trabecular bone is therefore primarily affected by pathologies in bone remodelling [32].”
BackgroundLiu, X., & Li, H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1374027 · Cited by 9
“Many immune and non-immune cells in periodontal tissue interact with osteoblasts and osteoclasts, which can regulate the balance of physiological bone formation and bone resorption (95, 96).”
BackgroundOsteoimmunology in bone malignancies: a symphony with evil
Song, C., Tong, T., Dai, B., Zhu, Y., Chen, E., Zhang, M., & Zhang, W. (2024) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2024.09.001 · Cited by 10
Nrf2 Activation as a Therapeutic Target for Flavonoids in Aging-Related Osteoporosis
Messeha, S. S., Fidudusola, F. F., Gendy, S., Latinwo, L. M., Odewumi, C. O., & Soliman, K. F. A. (2025) · Nutrients · doi:10.3390/nu17020267 · Cited by 9
“Increased osteoclast activity and production in OP and other bone illnesses promote unbalanced bone resorption/formation, decreasing bone density and increasing bone fracture risk [48,49].”
The bone-heart axis in the pathogenesis of cardiovascular diseases: A narrative review
Vergatti, A., Abate, V., Iannuzzo, G., Barbato, A., FILIPPO, G. D., & Rendina, D. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.103872 · Cited by 11
Arsenic and metabolic diseases: New insights from mesenchymal stem cells
Hu, Y., He, J., Ma, Y., Ge, L., Lou, B., Fang, X. D., Wang, H., & Xu, Y. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117299 · Cited by 9
Zhang, M., Xiong, W., Qiao, R., Li, M., Zhang, C., Yang, C., Zhu, Y., He, J., & Ma, Z. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1570157 · Cited by 10
“The process concludes with mineralization of the osteoid, thus completing bone remodeling (Feng and McDonald, 2011).”
Inhibitory effect of oolonghomobisflavan B on osteoclastogenesis by suppressing p38 MAPK activation
Lim, S.-M., Kim, T. H., Ihn, H. J., Lim, J., Kim, G., Choi, Y. H., Bae, J., Jung, J., Shin, H., Kim, J., et al. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127429 · Cited by 9
Li, J., Yuan, Y., Chan, W., Wei, W., Liu, X., Wang, M., Li, J., & Hao, L. (2023) · International Endodontic Journal · doi:10.1111/iej.13924 · Cited by 9
Pantoprazole‐Induced Bone Loss through Gastrin Secretion: A Stereological Study
Saki, F., Shams, M., Dastghaib, S., & Koohpeyma, F. (2023) · BioMed Research International · doi:10.1155/2023/2594664 · Cited by 9
“In connective tissue, mesenchymal stem cells group together and develop into osteoblasts [49].”
BackgroundPMAIP1, a novel diagnostic and potential therapeutic biomarker in osteoporosis
Li, T., Yuan, J., Xu, P., Jia, J., Zhao, J., Zhang, J., Ding, R., Zhao, X., He, D., Wu, T., et al. (2024) · Aging · doi:10.18632/aging.205553 · Cited by 9
Polyphenol Antioxidants and Bone Health: A Review
RAO, L. G. S., Kang, N., & Rao, A. V. (2012) · InTech eBooks · doi:10.5772/39287 · Cited by 9
Menopause and Exercise: Linking Pathophysiology to Effects
Atapattu, P. M., Fern, D., Wasalathanthri, S., & de Silva, A. (2015) · Archives of Medicine · Cited by 9
Glutamate signaling in non-neuronal tissues
Hinoi, E., & Yoneda, Y. (2012) · Folia Pharmacologica Japonica · doi:10.1254/fpj.139.165 · Cited by 9
Deng, Z., Wang, S., Heng, B. C., Yuan, C., & Zhang, C. (2016) · Biotechnology Letters · doi:10.1007/s10529-016-2142-z · Cited by 9
A New Clinically Relevant T-Score Standard to Interpret Bone Status in a Sheep Model
Heiß, C., Kern, S., Malhan, D., Böcker, W., Engelhardt, M., Daghma, D. E. S., Stötzel, S., Schmitt, J., Ivo, M., Kauschke, V., et al. (2017) · Medical science monitor basic research/Medical science monitor. Basic research · doi:10.12659/msmbr.905561 · Cited by 9
“However, different factors, such as menopause-related hormonal changes, affect bone homeostasis [2].”
BackgroundYao, R., NISHII, K., Kito, T., Teranishi, T., Sugiyama, T., Sakai, K., Matsubara, M., & Yamada, K. (2019) · Okajimas Folia Anatomica Japonica · doi:10.2535/ofaj.96.13 · Cited by 8
IDH2-Deficient Mice Develop Spinal Deformities With Aging
Chae, U., Park, N. R., Kim, E., CHOI, J.-Y., Yim, M., Lee, H., Lee, S., Lee, S., Park, J., & Lee, D. (2018) · Physiological Research · doi:10.33549/physiolres.933711 · Cited by 9
“Degeneration of bone remodeling function can induce osteoporosis and various diseases of bone metabolism (Feng & McDonald 2011).”
BackgroundLi, S., Li, X., He, F., Jiao, R., Zhang, S., & Li, Z. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.89652 · Cited by 9
“Physiological inhibition of the ERK gene contributes to the development of osteoporosis by inhibiting osteoblast differentiation and proliferation [22].”
BackgroundBone Tissue Disorders: Healing Through Coordination Chemistry
Barbosa, J. S., Mendes, R. F., Figueira, F., Gaspar, V. M., Mano, J. F., Braga, S. S., Rocha, J., & Paz, F. A. A. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202004529 · Cited by 9
Leto, G., Flandina, C., Crescimanno, M., Giammanco, M., & Sepporta, M. V. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118694 · Cited by 12
Geurtzen, K., López-Delgado, A. C., Duseja, A., Kurzyukova, A., & Knopf, F. (2022) · Development · doi:10.1242/dev.199803 · Cited by 11
Kim, S., Kim, H. J., Park, G. E., Lee, C. W., Synytsya, A., Capek, P., & Park, Y. I. (2022) · Marine Biotechnology · doi:10.1007/s10126-022-10136-w · Cited by 9
“An imbalance between these two processes, osteoblastic bone formation and osteoclastic bone resorption, during bone remodeling processes ultimately causes serious senile and/or postmenopausal OP (Eriksen 2010; Feng and McDonald 2011; Sozen et al.”
BackgroundRole of exosomes in bone and joint disease metabolism, diagnosis, and therapy
Li, Y., Huang, P., Nasser, M. I., Wu, W., Yao, J., & Sun, Y. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106262 · Cited by 9
Responds of Bone Cells to Microgravity: Ground-Based Research
Zhang, J., Li, J., Xu, H., Yang, P., Xie, L., Qian, A., Zhao, Y., & Shang, P. (2015) · Microgravity Science and Technology · doi:10.1007/s12217-015-9443-z · Cited by 9
“The coupled balance between bone formation and bone resorption is essential to maintain skeleton health (Feng and McDonald 2011).”
BackgroundA Combined Process Algebraic and Stochastic Approach to Bone Remodeling
Lió, P., Merelli, E., Paoletti, N., & Viceconti, M. (2011) · Electronic Notes in Theoretical Computer Science · doi:10.1016/j.entcs.2011.09.034 · Cited by 9
“Hence, the definition of faithful models for BR has a high social and clinical relevance in the prediction of bone diseases [5].”
BackgroundLi, C., Yu, L. J., Zhang, L., Zhang, S., Yao, W., & Zuo, Z. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.04.048 · Cited by 9
Park, S. Y., Choi, E. M., Suh, K. S., Kim, H.-S., Chin, S. O., Rhee, S. Y., Kim, D., Oh, S., & Chon, S. (2019) · Journal of Korean Medical Science · doi:10.3346/jkms.2019.34.e267 · Cited by 9
Ciliopathic micrognathia is caused by aberrant skeletal differentiation and remodeling
Paese, C. L. B., Brooks, E. C., Aarnio, M., & Brugmann, S. A. (2021) · Development · doi:10.1242/dev.194175 · Cited by 8
Xiong, Q., Zhang, L., Zhan, S., Ge, W., & Tang, P. (2016) · Proteome Science · doi:10.1186/s12953-016-0097-6 · Cited by 9
“Over-activation of bone resorption plays a critical role in the pathological mechanisms of osteoporosis [5].”
Down Regulation of Osteocalcin Gene in Chickens Treated with Cadmium
Ahmadi, Z., & Ashrafizadeh, M. (2019) · Iranian Journal of Toxicology · doi:10.32598/ijt.13.1.540.3 · Cited by 8
“For instance, excretion of low-molecular-mass proteins from the kidneys has been shown to occur following cadmium exposure (12).”
BackgroundInfluentialRadiation Induces Bone Microenvironment Disruption by Activating the STING-TBK1 Pathway
Wang, Y., Ren, L., Xu, L., Wang, J., Zhai, J., & Zhu, G. (2023) · Medicina · doi:10.3390/medicina59071316 · Cited by 8
“An intricate balance between bone-forming osteoblasts and bone-resorbing osteoclasts plays an important role in maintaining bone integrity and quality through direct cell-to-cell contact or through secretory proteins [46].”
BackgroundMesenchymal stem cell–derived extracellular vesicles in periodontal bone repair
Chen, M., Huang, B., & Su, X. (2025) · Journal of Molecular Medicine · doi:10.1007/s00109-025-02513-4 · Cited by 8
“Bone remodeling aims to restore a dynamic balance between osteoblast-mediated bone formation and osteoclast-mediated bone resorption [76].”
Ramani, H., Cleret‐Buhot, A., Sylla, M., Bunet, R., Bertrand, F., Peet, M.-M., Chartrand‐Lefebvre, C., Trottier, B., Thomas, R., Routy, J., et al. (2025) · Cells · doi:10.3390/cells14070481 · Cited by 9
“Under physiological conditions, the co-existence and balance between these two cell types is tightly regulated to maintain bone homeostasis and to avoid net changes in bone mass [57].”
Extracellular osmolarity regulates osteoblast migration through the TRPV4-Rho/ROCK signaling
Li, Y., Yang, Y., Wang, X., Li, L., & Zhou, M. (2025) · Communications Biology · doi:10.1038/s42003-025-07946-8 · Cited by 8
Kim, J., Lee, J.-E., Ryu, S. H., & Suh, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.013 · Cited by 8
Badawy, T., Kyumoto‐Nakamura, Y., Uehara, N., Zhang, J.-Q., Sonoda, S., Hiura, H., Yamaza, T., Kukita, A., & Kukita, T. (2019) · Laboratory Investigation · doi:10.1038/s41374-018-0179-4 · Cited by 8
Naini, A., Sudiana, I. K., Rubianto, M., Kresnoadi, U., & Latief, F. D. E. (2019) · Dental Journal (Majalah Kedokteran Gigi) · doi:10.20473/j.djmkg.v52.i1.p13-17 · Cited by 8
Vergatti, A., Abate, V., D’Elia, L., FILIPPO, G. D., Piccinocchi, G., Gennari, L., Merlotti, D., Galletti, F., Strazzullo, P., & Rendina, D. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02402-6 · Cited by 8
Nutraceuticals in osteoporosis prevention
Roseti, L., Borciani, G., Grassi, F., Desando, G., Gambari, L., & Grigolo, B. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1445955 · Cited by 12
“Secondary osteoporosis derives from pre-or co-existing pathologies, medical conditions, or medications interfering with physiological bone formation (35).”
BackgroundAlghamdi, F., Mokbel, K., Meertens, R. M., Obotiba, A. D., Alharbi, M., KNAPP, K. M., & Strain, W. D. (2024) · Viruses · doi:10.3390/v16111694 · Cited by 9
“Any interruption or abnormalities in the bone remodelling cycle will result in skeletal disorders with low-or high-bone-mass syndromes, which increase the possibility of fracture or metabolic diseases for which the skeletal system is responsible [82,83].”
Novel lactone‐layered double hydroxide ionomer powders for bone tissue repair
Zhou, T., McCarthy, E. D., Soutis, C., & Cartmell, S. H. (2020) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.34614 · Cited by 8
Seo, W., Lee, S.-H., Trần, P. T., Ngo, T. Q.-M., Kim, O., Le, T. H., Dang, N. H., Hwangbo, C., Min, B. S., & Lee, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155240 · Cited by 8
“Excessive osteoclast activity causes bone loss, which leads to numerous pathological bone diseases such as rheumatoid arthritis, tumor bone metastases, osteoporosis, and Paget’s disease [6,7].”
Background2-NPPA Mitigates Osteoclastogenesis via Reducing TRAF6-Mediated c-fos Expression
Chen, Z., Ding, M., Cho, E., Seong, J., Lee, S., & Lee, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.599081 · Cited by 8
Effects ofMelandrium firmumRohrbach on RANKL‑induced osteoclast differentiation and OVX rats
Kim, M., Kim, J., Hong, S., Kwon, B., Kim, E., Jung, H., & Sohn, Y. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12248 · Cited by 8
“This imbalance can result in osteoclast‐mediated bone diseases, such as rheumatoid arthritis, periodontal disease, Paget's disease and osteoporosis (4).”
Lim, H. J., Park, E.-J., Won, Y., Bak, S. G., Cheong, S. H., Lee, S. W., Lee, S. W., Lee, S., & Rho, M. (2021) · Molecules · doi:10.3390/molecules26226820 · Cited by 8
“Imbalances in bone resorption by osteoclasts and bone formation by osteoblasts cause severe bone disease [1,28].”
BackgroundHerrera-Rodríguez, S. E., García-Márquez, E., Padilla‐Camberos, E., & Espinosa‐Andrews, H. (2022) · Nutrients · doi:10.3390/nu14030422 · Cited by 8
“The imbalance of bone remodeling can trigger some clinical diseases, such as osteoporosis or osteopenia [2].”
BackgroundRole of chromatin modulator Dpy30 in osteoclast differentiation and function
Zhao, Y., Hao, X., Li, Z., Feng, X., Katz, J., Michalek, S. M., Jiang, H., & Zhang, P. (2022) · Bone · doi:10.1016/j.bone.2022.116379 · Cited by 8
Self-citationBue, M., Bright, E., Thillemann, T. M., Mosegaard, S. B., Hansen, T. B., Klebe, T., Mechlenburg, I., & Stilling, M. (2022) · Journal of Shoulder and Elbow Surgery · doi:10.1016/j.jse.2022.07.008 · Cited by 8
Wu, M., Hsu, W.-B., Chen, M.-H., & Shi, C. (2022) · Biomedicines · doi:10.3390/biomedicines10102355 · Cited by 8
“An imbalance between bone formation and resorption results in various osteopathic diseases, including osteoporosis [2].”
BackgroundHarun, N. H., Froemming, G. R. A., Ismail, A. M., Nawawi, H. M., Mokhtar, S. S., & Muid, S. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314616 · Cited by 8
“The disruption in the bone-forming activity interrupts the balanced tight coupling process between osteoblasts and osteoclasts in the bone remodeling cycle, leading to bone loss [10].”
BackgroundADR3, a next generation i-body to human RANKL, inhibits osteoclast formation and bone resorption
Qiu, H., Hosking, C., Rothzerg, E., Samantha, A., Chen, K., Kuek, V., Jin, H., Zhu, S., Vrielink, A., Lim, K., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.102889 · Cited by 8
“There are several advantages of an i-body compared to a conventional antibody: (1) high accessibility to targets, (2) extended paratopes (up to twice the length of typical human antibody complementarity determining regions), (3) high stability, (4) low cost of manufacture, (5) tailored half-life in humans, and (6) low…”
BackgroundDlk2 interacts with Syap1 to activate Akt signaling pathway during osteoclast formation
Chen, X., Chen, X., Chao, R., Wang, Y., Mao, Y., Fan, B., Zhang, Y., Xu, W., Qin, A., & Zhang, S. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06107-1 · Cited by 8
“Bone loss is caused by excessive osteoclast formation and continuously degraded bone matrix, giving rise to bone disorders such as osteoporosis [6, 7], osteoarthritis [8, 9], rheumatoid arthritis [10] and periodontitis associated bone loss [11].”
DAP12 Overexpression Induces Osteopenia and Impaired Early Hematopoiesis
Despars, G., Pandruvada, S. N. M., Anginot, A., Domenget, C., Jurdic, P., & Mazzorana, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065297 · Cited by 8
“imbalances between bone resorption and bone formation [3].”
BackgroundYeom, M., Kim, E., Kim, J., Jung, H., & Sohn, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01314 · Cited by 8
“Normally, bone formation and resorption are tightly coordinated during the remodeling cycle, but when this coordination is lost in certain pathological conditions such as lower estrogen levels during menopause and postmenopause, abnormal bone remodeling, mainly leading to bone loss, ensues (Feng and McDonald, 2011).”
BackgroundKoek, W. N. H., van der Eerden, B. C. J., Alves, R. D. A. M., van Driel, M., Schreuders‐Koedam, M., Zillikens, M. C., & van Leeuwen, J. P. T. M. (2016) · Bone · doi:10.1016/j.bone.2016.11.010 · Cited by 8
Hematopoiesis and bone remodeling
Suda, T. (2011) · Blood · doi:10.1182/blood-2011-03-344127 · Cited by 8
Smith, A. E., Muralidharan, A., & Smith, M. T. (2022) · Discover Oncology · doi:10.1007/s12672-022-00569-z · Cited by 7
Molecular Signaling Pathways and MicroRNAs in Bone Remodeling: A Narrative Review
Singh, M., Singh, P., Singh, B., Sharma, K., Kumar, N., Singh, D., & Mastana, S. S. (2024) · Diseases · doi:10.3390/diseases12100252 · Cited by 8
“…uncontrolled events of bone tissue degradation, the formation of osteoid (the unmineralized part of a bone matrix) and fibrosis (the thickening of tissue) [31]. miRNAs are important epigenetic managers which regulate gene expression by targeting mRNA and suppress post-transcriptional gene function.”
BackgroundLi, H., Fu, Z., Tao, A., Wu, T., Zhan, X., Tang, H., Cui, X., Ma, Z., Li, C., Jiang, J., et al. (2024) · Bone · doi:10.1016/j.bone.2024.117340 · Cited by 7
Lee, S. H., Lee, K. H., Kim, D. H., Jeon, C., Whangbo, M., Jo, H.-R., Youn, J., Lee, C., Choi, S. H., Park, Y., et al. (2025) · Arthritis Research & Therapy · doi:10.1186/s13075-025-03474-2 · Cited by 8
“However, an imbalance in bone remodeling leads to various forms of bone disorder such as osteoporosis, osteopenia, osteopetrosis, or AS [44].”
Li, Y., Yang, Y., Guo, C., & Cai, H. (2025) · Bone · doi:10.1016/j.bone.2025.117461 · Cited by 7
Vemparala, B., Ji, M., Mageswaran, P., Knapik, G. G., Dibs, K. N., Blakaj, D. M., Bourekas, E. C., Mendel, E., Marras, W. S., & Soghrati, S. (2025) · International Journal for Numerical Methods in Biomedical Engineering · doi:10.1002/cnm.70097 · Cited by 7
“This does not imply that m = 2.5 , 3.0, and 5.0 are essentially poor fits, as these outliers may represent subjects with specific health conditions resulting in atypical bone re-modeling rates [77].”
InfluentialModelling Osteoporosis in Pre-Clinical Research—Challenges, Trends and New Approaches
Plank, J., Damerau, A., Chacon, M. S., Hoff, P., Buttgereit, F., & Pfeiffenberger, M. (2025) · Cells · doi:10.3390/cells14211649 · Cited by 8
Osteoporotic Fractures of the Proximal Humerus: an In-Depth Review of Current Management Options
Girgin, A. B., Acar, A., Torun, Ö., & Çevi̇k, H. B. (2025) · Current Osteoporosis Reports · doi:10.1007/s11914-025-00945-y · Cited by 7
“In healthy individuals, new bone formation equals bone resorption, thanks to the balance between osteoclasts, osteoblasts, and osteocytes [ 11 , 12].”
FXR in bone metabolism: An emerging regulator
Rizvi, S. M. M. H., Aihemaiti, S., Kan, Y., Tao, S., & Liu, H. (2026) · iScience · doi:10.1016/j.isci.2026.114842 · Cited by 8
Chen, Z., Luo, Z., Greenblatt, M. B., Wu, Z., & Xu, R. (2026) · Bone Research · doi:10.1038/s41413-026-00534-4 · Cited by 9
“…(ITAM) and ras homolog family member A (RhoA) signaling to block RANKL-driven differentiation, 142 and NRP1 competes with the triggering receptor expressed on myeloid cells 2 (TREM2) – DNAX-activating protein of 12 kD (DAP12) complex for PlexinA1 binding to further restrain osteoclastogenesis.”
Pilot Study: Short Term Impact of Radiation Therapy on Bone Mineral Density and Bone Metabolism
Thio, Q. C. B. S., Palthe, O. D. R. V. W., Bramer, J. A. M., DeLaney, T. F., Bredella, M. A., Dempster, D. W., Zhou, H., Hornicek, F. J., Chen, Y.-L. E., & Schwab, J. H. (2023) · Calcified Tissue International · doi:10.1007/s00223-023-01149-1 · Cited by 7
“Bone-lining cells, osteocytes, osteoblasts and osteoclasts are the key players in this remodeling process and a tight balance between bone resorption by osteoclasts and bone formation by osteoblasts is needed to ensure bone quality [20].”
Hà, M. T., Gal, M., Kim, J. A., Lee, J., & Min, B. S. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.107066 · Cited by 7
Tan, M., Zhu, S.-X., Wang, G.-P., & Liu, Z. (2024) · Scientific Reports · doi:10.1038/s41598-024-57352-z · Cited by 8
“Notably, IL-6 and TNF-alpha, stimulated by IL-1 and TNF, respectively, incite an inflammatory response that encourages osteoclast formation and their bone-resorbing activities 60 .”
BackgroundKim, H., Kim, B., Ahn, S. H., Lee, S. H., & Koh, J. (2014) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-014-0634-2 · Cited by 7
(2013) · CRC Press eBooks · doi:10.1201/b15986 · Cited by 7
Park, E., Kim, M.-C., Choi, C. W., Kim, J., Jin, H., Lee, R., Lee, J., Park, J.-H., Huh, D., & Jeong, S. (2016) · Molecules · doi:10.3390/molecules21091260 · Cited by 8
“In the skeletal system, homeostasis of bone remodeling is maintained by the balance of bone resorption and bone formation [1,2].”
InfluentialGregureć, D., Πολιτάκος, Ν., Yate, L., & Moya, S. E. (2019) · Molecular Systems Design & Engineering · doi:10.1039/c8me00089a · Cited by 7
Glycyrrhizin improves bone metabolism in ovariectomized mice via inactivating NF-κB signaling
Tang, Y., Lv, X., Bao, Y., & Wang, J. R. (2020) · Climacteric · doi:10.1080/13697137.2020.1828853 · Cited by 7
Amorim, T., Freitas, L., Metsios, G. S., Gomes, T. N., Wyon, M. A., Flouris, A. D., Maia, J. A. R., Marques, F., Nogueira, L., Adubeiro, N., et al. (2021) · Archives of Osteoporosis · doi:10.1007/s11657-021-01005-5 · Cited by 7
Ballato, E., Deepika, F., Prado, M., Russo, V., Fuenmayor, V., Bathina, S., Villareal, D. T., Qualls, C., & Armamento‐Villareal, R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.936159 · Cited by 7
“A host of factors can lead to disorders of bone remodeling including but not limited to aging, menopause, hormonal imbalance, vitamin D deficiency, medications, immobilization, and chronic kidney disease, among others (1).”
Background
Metadata
- Authors
- Feng, X., & McDonald, J. M.
- Affiliations
- University of Alabama at Birmingham (US)
- ORCID
- Feng, Xu
- Venue
- Annual Review of Pathology: Mechanisms of Disease
- Publisher
- Annual Reviews
- Published
- 2011-02-28
- Volume
- 6
- Issue
- 1
- Pages
- 121-145
- ISSN
- 1553-4006 (ISSN-L)
- 1553-4014
- PMC
- PMC3571087
- OpenAlex
- W2166266977
- Cited by
- 1,272
- References
- 171
- Citations by year
- 2026: 59 · 2025: 109 · 2024: 102 · 2023: 124 · 2022: 135 · 2021: 142 · 2020: 107 · 2019: 117 · 2018: 86 · 2017: 68 · 2016: 59 · 2015: 47 · 2014: 36 · 2013: 37 · 2012: 29
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Annual Review of Pathology Mechanisms of Disease (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA109119)
- National Institute of Neurological Disorders and Stroke (R21NS061677, NS061677)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (5P30 AR0406031, R01AR047830, AR 47830, R01AR050235)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- bone remodeling, bone resorption, bone formation, osteoclasts, osteoblasts, bone disease, menopause, hormonal changes, age-related bone loss, physical activity, drug-induced bone loss, mineral homeostasis, pathophysiology
- MeSH terms
- Animals, Bone Diseases, Humans, Bone Remodeling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
